Snow Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$9.8M Buy
250,171
+51,901
+26% +$2.02M 1.39% 28
2021
Q1
$7.18M Buy
+198,270
New +$7.04M 1.04% 35
2018
Q2
Sell
-6,063
Closed -$204K 145
2018
Q1
$204K Buy
+6,063
New +$208K 0.01% 132

Other funds holding PFE

Snow Capital Management's PFE Position: Q2 2021 in Review

Snow Capital Management increased its Pfizer (PFE) stake by 26% in Q2 2021, buying an estimated $2.02M and bringing the position to 250,171 shares worth $9.8M. The position accounts for 1.39% of the portfolio, ranked #28.

Snow Capital Management first reported a position in PFE in Q1 2018 and has held it in 3 quarters since. 2,733 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

  • Snow Capital Management held 250,171 shares of Pfizer worth $9.8M as of Q2 2021.
  • Snow Capital Management bought 51,901 Pfizer shares in Q2 2021, an estimated $2.02M.
  • Pfizer made up 1.39% of Snow Capital Management's portfolio in Q2 2021, its #28 holding.
  • Snow Capital Management first reported a position in Pfizer in Q1 2018 and has held it in 3 quarters since.
  • 2,733 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Snow Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.